Navigation Links
President Urges to Avoid Discrimination Against AIDS Patients

The President, Shri A.P.J.Abdul Kalam has urged Parliamentarians to see that a robust and effective legislation which would prevent discrimination against AIDS// patients in their day-to-day life is brought into force within the next six months. The President was addressing a function on World AIDS Day organized by Parliamentarians Forum on HIV/AIDS and NACO here today.

The President made the following suggestions to MPs, research laboratories, the Pharma industry and the Health Ministry: Considering taking up control and prevention of HIV/AIDS from their constituency within the next five years as an important mission; Members of Parliament can create an organized awareness campaign among all rural youth and women in their constituency for enabling prevention of infection among this population through a well-organised prevention programme; Creating a mechanism in partnership with societal organizations, medical institutions and Government for testing blood for any contamination and ensuring that contaminated blood is not stored in any blood banks in their constituency; Considering facilitating hassle-free availability of all services such as schooling for children, rural employment, nutrition, health services, banking credit, training and employment to all people with HIV/AIDS in their constituency. This will enable improvement of the quality of life of people living with HIV/AIDS and make them feel that they are an integral part of society; Consider creation of a HIV/AIDS Foundation in partnership with philanthropists and NGOs in their constituency, which can provide financial assistance to needy HIV/AIDS patients for their treatment and sustenance and to identify individual groups and encourage their work to find out two or three herbal based solutions for the cure of HIV and for a HIV vaccine.

The Vice-President Shri Bhairon Singh Shekhawat in his address said that the YUVA campaign spearheaded by the youth has the potential to play a pio
'"/>




Page: 1 2

Related medicine news :

1. Past President Narayanans Condition Still Critical
2. President and Founder of National Obesity Forum Resigns
3. President Bush Urges Citizens to Invest In Health Savings Account (HSAs)
4. President Bush proposes HSAs scheme for the benefit of both the workers and the country
5. President’s verdict: no need to panic over bird fl
6. Delhi Hospitals On Standby For President Bush
7. Former IMO President Shows Interest In Winning General Election
8. Chicken Dishes Were Off The Menu At Pakistan Presidents House
9. Man Appeals to President to Save His Ailing Son
10. President Kalam Meets Striking Medicos However Stir to Continue
11. Medicos Seek President’s Permission For Self-Immolatio
Post Your Comments:
(Date:12/2/2008)...G, Mich., Dec. 2 Senior...nsurance companies gathered today to,oppose effor...ss legislation,through the lame duck session of t...f life or death for many of us in Michigan," said,...igan Disability Rights,Coalition. "A vote for thi...
(Date:12/2/2008)... Appointment of enterprise soft...celerate growth in revenue and subscribers of Yugm... Minneapolis, MN (PRWEB) December 2...rvice that lets people connect and collaborate ins...nt of Vas Bhandarkar as Chief Executive Officer. ,...
(Date:12/2/2008)...UMBUS, Ohio)Rare injuries accounted for 3.5 percen...007, according to the first study to examine rare ...es. Rare injuries include eye injuries, dental inj...and heat illness, which may result in high morbidi...ng consequences. , Football was associated with ...
(Date:12/2/2008)...T, Dec. 2 United America... owns and provides comprehensive healthcare,manag...ennessee, today,announced that its Board of Direc...horizing the Company to repurchase up to $1.0 mill... program allows for the Company,s common shares to...
Breaking Medicine News(10 mins):Health News:Opposition Continues to Grow to Blues' Legislation 2Health News:Opposition Continues to Grow to Blues' Legislation 3Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 2Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 3Health News:United American Healthcare Corporation Announces Stock Repurchase Program 2
...e. According to a recent study researchers find sm...eases the risk of having a baby with a cleft lip. ...d who were interviewed when their babies were abou...t the mother’s smoking habits before and during pr...
...the first step in the path for a treatment for hum...t time they have found a successful way to deliver... Gene therapy for muscular dystrophy has been a h...a delivery method for the whole body has been a ma...
... people infected with both HIV and hepatitis C hav...eir study, patients who are treated with a newer c...to rid their bodies of HCV than those who receive ...nt because as many as 300,000 of the estimated 1 m...
...may keep your blood pressure under control. Resear...who drank between 120 milliliters and 599 millilit...46-percent decreased risk of developing hypertensi...ople who consumed more than 600 milliliters a day ...
Other Medicine News:
(Date:12/1/2008)... ENB-0040 at Children,s Hospital, Health Sciences ...Newswire/ -- Enobia Pharma, an emerging Canadian b...utics for serious bone disorders, today announced ...ram for hypophosphatasia was dosed. Enobia is inve...B-0040 for the treatment of this rare and often cr...
(Date:12/1/2008)...cember 9 at 11:00 am ET to Discuss Phase 2 Study R...Calif., Dec. 1 Sunesis...rmaceutical company focused on the development and...oday announced new data from its studies of vorelo...ted during the 50th American Society of Hematology...
(Date:11/28/2008)...re/ -- German biotech company,Partec is expanding...ng and,AIDS patient follow-up diagnostics for dev... 2.5 million patient tests have been performed wit...low" system, supporting already,more than 1 milli...n of the,Partec innovation, the average cost of E...
(Date:11/26/2008)...ANKLIN, Mass., Nov. 26 P...ced today that it has received full approval from ...s U.S. pivotal trial to study the effectiveness of...ed therapy in the prevention of Contrast-Induced N... PLC,s request to expand their investigation from ...
Breaking Medicine Technology:Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Advanced Life Sciences Enters Into Definitive Securities Purchase Agreements for 2420 Million with New and Existing Institutional Investors 2134 1Advanced Life Sciences Enters Into Definitive Securities Purchase Agreements for 2420 Million with New and Existing Institutional Investors 2134 2Abdominal Fat Tied to High Risk for Coronary Trouble 8051 1Abdominal Fat Tied to High Risk for Coronary Trouble 8051 2Scientists seek to assess the microbial risks in the water we drink 8047 1Scientists seek to assess the microbial risks in the water we drink 8047 2Scientists seek to assess the microbial risks in the water we drink 8047 3Building blocks of life formed on Mars 1544 1Building blocks of life formed on Mars 1544 2
...east 45% additional,reduction in patients, LDL-cho...owering therapies, CARLSBAD, Calif., May 17, 2007 ...c. announced updated results from its ongoing,Phas... homozygous,familial hypercholesterolemia (HoFH), ...t the of Cardiology Annual Scientific Session,(ACC...
... Than for Asthma,Rheumatoid Arthritis and Migrain...y three out of,four ulcerative colitis (UC) suffer...rvey say not feeling well has become a normal part...ive when it comes,to their relationship with a spo...nt) and their emotional state (82 percent). , UC p...
Other Medicine Technology:Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 2Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 3Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 4Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 5Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 2Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 3Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 4Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 5Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 6Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 7Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 8Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 9
Used for temporary internal drainage from the ureteropelvic junction to the bladder. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is advised; C-Flex
Used for catheter or instrument introduction. The dual knobs allow the sheath to be peeled away and removed. The maximum diameter of the catheter or instrument to be introduced should be measured to
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use.
Used to establish a percutaneous tract into the renal pelvis for catheter placement or stone manipulation. Supplied sterile in peel-open packages. Intended for one-time use.
Medicine Products: